Cargando…
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
Cancer is a highly heterogeneous disease with different functional disorders among individuals. The initiation and progression of cancer is usually related to dysregulation of local regions within pathways. Identification of individualized risk pathways is crucial for revealing the mechanisms of tum...
Autores principales: | Xu, Yanjun, Wang, Jingwen, Li, Feng, Zhang, Chunlong, Zheng, Xuan, Cao, Yang, Shang, Desi, Hu, Congxue, Xu, Yingqi, Mi, Wanqi, Li, Xia, Cao, Yan, Zhang, Yunpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842010/ https://www.ncbi.nlm.nih.gov/pubmed/35222843 http://dx.doi.org/10.1016/j.csbj.2022.01.022 |
Ejemplares similares
-
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019) -
LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies
por: Xu, Yanjun, et al.
Publicado: (2017) -
Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies
por: Feng, Li, et al.
Publicado: (2015) -
Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways
por: Li, Chunquan, et al.
Publicado: (2013) -
Characterizing the Network of Drugs and Their Affected Metabolic Subpathways
por: Li, Chunquan, et al.
Publicado: (2012)